Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transforming Growth Factor-Beta Orchestrates Tumour and Bystander Cells in B-Cell Non-Hodgkin Lymphoma. | Cancers (Basel) | 2022 | 35406544 | PubTator, text mining | PubMed |
| Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. | Mol Ther | 2022 | 35405312 | PubTator, text mining | PubMed |
| Cellular Interaction Analysis Characterizing Immunosuppressive Microenvironment Functions in MM Tumorigenesis From Precursor Stages. | Front Genet | 2022 | 35401705 | PubTator, text mining | PubMed |
| A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy. | BMC Cancer | 2022 | 35397600 | PubTator, text mining | PubMed |
| Use of miRNA Sequencing to Reveal Hub miRNAs and the Effect of miR-582-3p/SMAD2 in the Progression of Hepatocellular Carcinoma. | Front Genet | 2022 | 35386287 | PubTator, text mining | PubMed |
| Targeting transforming growth factor-β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin. | Clin Transl Med | 2022 | 35384373 | PubTator, text mining | PubMed |
| Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopulation-specific miRNA expression sets in acute and stable coronary artery disease. | Sci Rep | 2022 | 35379829 | PubTator, text mining | PubMed |
| Flavonoids Inhibit Cancer by Regulating the Competing Endogenous RNA Network. | Front Oncol | 2022 | 35371996 | PubTator, text mining | PubMed |
| Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. | Nat Commun | 2022 | 35365629 | PubTator, text mining | PubMed |
| The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. | Stem Cell Res Ther | 2022 | 35365226 | PubTator, text mining | PubMed |
| Altered propionate metabolism contributes to tumour progression and aggressiveness. | Nat Metab | 2022 | 35361954 | PubTator, text mining | PubMed |
| Genome Wide Scan to Identify Potential Genomic Regions Associated With Milk Protein and Minerals in Vrindavani Cattle. | Front Vet Sci | 2022 | 35359668 | PubTator, text mining | PubMed |
| Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis. | Front Oncol | 2022 | 35356208 | PubTator, text mining | PubMed |
MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3-kinase/Akt signaling pathway. | Bioengineered | 2022 | 35353027 | PubTator, text mining | PubMed |
| An 8-gene machine learning model improves clinical prediction of severe dengue progression. | Genome Med | 2022 | 35346346 | PubTator, text mining | PubMed |
| Oocyte maturation abnormalities - A systematic review of the evidence and mechanisms in a rare but difficult to manage fertility pheneomina. | Turk J Obstet Gynecol | 2022 | 35343221 | PubTator, text mining | PubMed |
| Identification of hub genes for adult patients with sepsis via RNA sequencing. | Sci Rep | 2022 | 35332254 | PubTator, text mining | PubMed |
| Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers. | Int J Mol Sci | 2022 | 35328568 | PubTator, text mining | PubMed |
| Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes. | Biomolecules | 2022 | 35327565 | PubTator, text mining | PubMed |
| At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy. | Cancers (Basel) | 2022 | 35326728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=31